Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the Study is to determine the prophylactic effects of CVT-E002 treatment for
upper respiratory tract infections in healthy adult employees working with residents in
continuing care facilities. It is hypothesized that the use of CVT-E002 will effectively
reduce the incidence, severity and duration of upper respiratory infections among the
participants when compared to placebo.